Literature DB >> 696671

Clinical significance of citrobacter isolates.

G R Hodges, C E Degener, W G Barnes.   

Abstract

Little is know about the clinical significance of isolating Citrobacter in the clinical laboratory. During a one-year period, 116 Citrobacter isolates were obtained from 77 patients with 83 suspected infectious episodes. The majority of the suspected infectious episodes involved the urinary tract (45%) or respiratory tract (41%). Citrobacter diversus was associated with 42% of the episodes, Citrobacter freundii with 29%, and Citrobacter species with 29%. In 42% of the suspected infectious episodes, the presence of Citrobacter was considered clinically significant; in the others, the significance of the Citrobacter isolates was indeterminate or considered to be commensal. Two thirds of the significant infections were hospital-acquired. Most patients (73%) from whom Citrobacter was cultured had underlying diseases or factors predisposing to infection. These data suggest that Citrobacter is a cause of significant opportunistic nosocomial infection in the hospital.

Entities:  

Mesh:

Year:  1978        PMID: 696671     DOI: 10.1093/ajcp/70.1.37

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Citrobacter sedlakii meningitis and brain abscess in a premature infant.

Authors:  J Dyer; K C Hayani; W M Janda; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Detection and quantification of Citrobacter freundii and C. braakii by 5'-nuclease polymerase chain reaction.

Authors:  Eva Kaclíková; Klára Krascsenicsová; Domenico Pangallo; Tomás Kuchta
Journal:  Curr Microbiol       Date:  2005-09-16       Impact factor: 2.188

3.  Neonatal citrobacter sepsis: clinical and epidemiological aspects.

Authors:  G G Christo; J Mathai; B Nalini; M Baliga; A Venkatesh
Journal:  Indian J Pediatr       Date:  1990 Nov-Dec       Impact factor: 1.967

4.  Citrobacter freundii invades and replicates in human brain microvascular endothelial cells.

Authors:  J L Badger; M F Stins; K S Kim
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Authors:  Peter W Kim; Anthony D Harris; Mary-Claire Roghmann; J Glenn Morris; Arjun Strinivasan; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  Citrobacter infections in a general hospital: characteristics and outcomes.

Authors:  G Samonis; D E Karageorgopoulos; D P Kofteridis; D K Matthaiou; V Sidiropoulou; S Maraki; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-06       Impact factor: 3.267

7.  Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.

Authors:  G Samonis; E Anaissie; L Elting; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

8.  In vitro susceptibility of Citrobacter species to various antimicrobial agents.

Authors:  G Samonis; D H Ho; G F Gooch; K V Rolston; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

9.  Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples.

Authors:  H Schmidt; M Montag; J Bockemühl; J Heesemann; H Karch
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  Antimicrobial susceptibility patterns of urinary pathogens in Trinidad, 1996-1999.

Authors:  F A Orrett
Journal:  J Natl Med Assoc       Date:  2003-05       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.